AI Article Synopsis

  • - This study examined how different interpretations of guidelines for outlining left-sided internal mammary lymph nodes (IMN) affect radiation exposure to nearby organs in breast cancer patients.
  • - Using a cohort of 95 patients, it compared the NKI's interpretation with a deep learning model based on Danish guidelines, finding significant geometric and dosimetric differences, especially regarding heart dose.
  • - The results indicated that variability in guideline interpretations can lead to higher heart radiation doses, highlighting the importance of establishing a uniform consensus in treatment practices to improve patient outcomes.

Article Abstract

Background And Purpose:  This study aimed at investigating the dosimetric impact on organs at risk, when the left-sided internal mammary lymph nodes (IMN) were delineated with two interpretations of the same guideline.

Materials And Methods:  The cohort consisted of 95 left-sided breast cancer patients with indication for irradiation of the CTVn_IMN treated at the Netherlands Cancer Institute (NKI). The NKI interpretation of the ESTRO guidelines was in the clinical structure sets (CTVn_IMN_NKI). A deep learning model was used as second interpretation of the guideline, based on a Danish consensus interpretation (CTVn_IMN_DK). The geometrical similarity was evaluated with the Dice Similarity Coefficient (DSC), volume, width, distance to sternal bone (SB) and maximum distance between the interpretations in the medial direction. Treatment plans were generated for both CTVn_IMNs. Mean heart dose (MHD) was correlated with the geometrical metrics.

Results:  62 patients were eligible for analysis. The geometric comparison showed a median volume of 9.59 ml/7.19 ml for the CTVN_IMN_NKI/CTVn_IMN_DK along with a median DSC of 0.63. The width and distance from SB were significantly different, with a median width of 18.2 mm/14.7 mm and distance to SB of 3.4 mm/5.1 mm for CTVn_IMN_NKI/CTVn_IMN_DK. The MHD was significantly higher with the CTVn_IMN_NKI. The strongest correlation was found between MHD and maximum medial difference between the CTVn_IMN in slices where the heart was present.

Conclusions: Differences in interpretations of the CTVn_IMN delineation guidelines were found, resulting in significant differences in MHD. For the individual patients, the dosimetric differences may impact treatment decisions, underscoring the need for strong consensus across borders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625340PMC
http://dx.doi.org/10.1016/j.phro.2024.100676DOI Listing

Publication Analysis

Top Keywords

internal mammary
8
mammary lymph
8
breast cancer
8
cancer patients
8
width distance
8
geometrical dosimetrical
4
dosimetrical evaluation
4
interpretations
4
evaluation interpretations
4
interpretations european
4

Similar Publications

Background: We investigated the perioperative outcome and oncologic safety of performing nipple-sparing mastectomy (NSM) through a single axillary incision (NSM-SAI) compared with performing NSM through a conventional incision (NSM-C).

Methods: We retrospectively reviewed 725 patients who underwent NSM for breast cancer between January 2010 and December 2023; 333 patients who underwent NSM with immediate reconstruction (IR) were enrolled. Surgical outcomes and oncologic outcomes of NSM-C (n = 184), NSM performed through SAI with a freehand approach (NSM-SAI-F; n = 92), and with an endoscopic approach (NSM-SAI-E; n = 57) were demonstrated.

View Article and Find Full Text PDF

Introduction: Breast cancer liver metastasis presents a significant challenge in clinical oncology, with limited treatment options and poor prognosis. This case series study explores the extended survival achieved in breast cancer patients with liver metastases through a combination of surgical and medical interventions.

Case Presentation: We present three cases of Javanese female patients with breast cancer (51 years old, 42 years old, and 55 years old) with liver metastases who underwent hepatic resection followed by systemic therapy.

View Article and Find Full Text PDF

Breast Cancers With Intermediate Estrogen Receptor Expression: Characteristics, Prognosis and Treatment.

Clin Breast Cancer

December 2024

Algoma District Cancer Program, Sault Area Hospital, Sault Ste Marie, Ontario, Canada; Division of Clinical Sciences, Section of Internal Medicine, Northern Ontario School of Medicine, Sudbury, Ontario, Canada. Electronic address:

In the era of personalized oncology biomarkers that identify subgroups of specific cancers and help predict response to specific therapies are critical tools for prognosis determination and therapeutic decisions. The Estrogen Receptor (ER) had been one of the first biomarkers used in breast cancer and has helped advance the field of breast oncology by contributing to the success of hormonal therapies for the ER positive subgroup of the disease. Expression of the receptor in 1% or more of tumor cells in immunohistochemical sections define currently the ER positive subgroup of breast cancers, which may be treated with regimens that include hormonal inhibitors.

View Article and Find Full Text PDF

Introduction: Antibody-drug conjugates (ADCs) trastuzumab-deruxtecan (T-DXd) and sacituzumab-govitecan (SG) provided significant progression-free survival (PFS) and overall survival (OS) improvements over chemotherapy (CT) in pretreated hormone receptor-positive (HR+) and triple-negative (TN)/HER2-low metastatic breast cancer (MBC). However, no direct comparison between the two exists, nor with the more recent datopotamab-deruxtecan (Dato-DXd).

Methods: We conducted a network meta-analysis (NMA) to compare efficacy and safety of T-DXd and SG in CT-pretreated HR+ and TN/HER2-low MBC and assess their benefit over standard CT, exploring also a comparison with Dato-DXd.

View Article and Find Full Text PDF

Interactively Fusing Global and Local Features for Benign and Malignant Classification of Breast Ultrasound Images.

Ultrasound Med Biol

December 2024

School of Instrumentation and Optoelectronics Engineering, Beihang University, Beijing, China. Electronic address:

Objective: Breast ultrasound (BUS) is used to classify benign and malignant breast tumors, and its automatic classification can reduce subjectivity. However, current convolutional neural networks (CNNs) face challenges in capturing global features, while vision transformer (ViT) networks have limitations in effectively extracting local features. Therefore, this study aimed to develop a deep learning method that enables the interaction and updating of intermediate features between CNN and ViT to achieve high-accuracy BUS image classification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!